Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3

[img] Text
art%3A10.1007%2Fs00259-014-2798-3.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (766kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

08 Faculty of Science > Departement of Chemistry and Biochemistry

UniBE Contributor:

Türler, Andreas

Subjects:

500 Science > 570 Life sciences; biology
500 Science > 540 Chemistry

ISSN:

1619-7070

Publisher:

Springer

Language:

English

Submitter:

Franziska Bornhauser-Rufer

Date Deposited:

02 Mar 2015 09:49

Last Modified:

24 Aug 2015 14:26

Publisher DOI:

10.1007/s00259-014-2798-3

BORIS DOI:

10.7892/boris.63927

URI:

https://boris.unibe.ch/id/eprint/63927

Actions (login required)

Edit item Edit item
Provide Feedback